- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in piramal pharma
Piramal Pharma Records Net Loss Of Rs 99 Cr In Q1FY24
Piramal Pharma recorded a net loss of Rs 99 crore against a net loss of Rs 109 crore recorded in the corresponding quarter of the previous year
Read More
Q2 Results: Piramal Pharma Registers Loss Of Rs 37 Cr, EBITDA Rises By 2.2%
Piramal Pharma, an Indian pharmaceuticals company, today announced its consolidated results for the Second Quarter and Half Year ended 30th September 2022. The pharma company in the second quarter has reported a net loss of Rs 37 crores in its first quarterly results after getting listed on BSE
Read More
Piramal Pharma Lists On Stock Exchanges After Demerger
Last week, Piramal Pharma said that it has received an approval from the Securities and Exchange Board of India (Sebi) to list shares on the stock exchange
Read More
Piramal Pharma Invests Rs 101.77 Cr For Minority Stake In Yapan Bio
The Mumbai-based company has acquired a 27.78 per cent stake in Yapan as a result of the investment
Read More
Piramal Pharma Completes Acquisition Of Hemmo Pharmaceuticals
Shares of Piramal Enterprises were trading at Rs 2,463.05, up 0.69 per cent on the BSE.
Read More
Piramal Pharma To Acquire 100% Stake In Hemmo Pharma For Rs 775 Cr
Consequent to the acquisition, Hemmo Pharmaceuticals Pvt Ltd would become a wholly-owned subsidiary of Piramal Pharma Ltd (PPL)
Read More
Piramal Pharma Solutions Invests Around $32 Million To Expand Michigan Facility
The company is investing the amount in the facility to keep up with expected demand based on current forecasts, including potential new opportunities
Read More
Carlyle Group To Buy 20% Stake In Piramal Pharma For Over Rs 3,700 Cr
The capital raise will accelerate Piramal Pharma's organic and inorganic growth plans,
Read More
Carlyle To Pick Up 20 % Stake In Piramal Pharma Business For $490 Million
The transaction values Piramal Pharma at an enterprise value of 2.7 billion dollars with an upside component of up to 360 million dollars depending on the company's FY21 performance.
Read More
Piramals To Invest More In US Custom Manufacturing Space
The latest $25 million investment is on the back of fast growing sterile (injections, ophthalmic solutions etc) market in the US
Read More